Sandoz Group AG (SDZNY)
SDZNY Stock Price Chart
Explore Sandoz Group AG interactive price chart. Choose custom timeframes to analyze SDZNY price movements and trends.
SDZNY Company Profile
Discover essential business fundamentals and corporate details for Sandoz Group AG (SDZNY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Oct 2023
Employees
22.05K
Website
https://www.sandoz.comCEO
Richard Saynor
Description
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.
SDZNY Financial Timeline
Browse a chronological timeline of Sandoz Group AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 3 Mar 2026
Earnings released on 7 Aug 2025
Dividend declared on 13 Mar 2025
A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 3 Jun 2025.
Earnings released on 5 Mar 2025
Earnings released on 30 Oct 2024
Earnings released on 8 Aug 2024
Dividend declared on 3 Apr 2024
A dividend of $0.50 per share was announced, adjusted to $0.50. The dividend was paid on 18 Jun 2024.
SDZNY Stock Performance
Access detailed SDZNY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.